Terms: = Gastric cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
572 results:
1. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
2. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis.
Li D; Huang P; Xia L; Leng W; Qin S
Int Immunopharmacol; 2024 Apr; 131():111836. PubMed ID: 38479160
[TBL] [Abstract] [Full Text] [Related]
4. Creating a Framework for Treating Autoimmune Gastritis-The Case for Replacing Lost Acid.
Taylor L; McCaddon A; Wolffenbuttel BHR
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474790
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
[TBL] [Abstract] [Full Text] [Related]
6. Predictive Value of a New Muscle Parameter in Patients with Resectable gastric cancer: A Pooled Analysis of Three Prospective Trials.
Zhong Q; Huang JB; Lu J; Xue LW; Lin GT; Xie JW; Lin JX; Zheng CH; Huang CM; Li P
Ann Surg Oncol; 2024 May; 31(5):3005-3016. PubMed ID: 38270825
[TBL] [Abstract] [Full Text] [Related]
7. FGF2 drives osteosarcoma metastasis through activating fgfr1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
8. An Investigation of the Effects of
Jin YC; Dong LJ; Yang QY; Xiong WN; Wang WY; Feng XH; Yu W; Huang W; Chen BF
Biomed Environ Sci; 2023 Sep; 36(9):814-825. PubMed ID: 37803894
[TBL] [Abstract] [Full Text] [Related]
9. Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway.
Li C; Wang S; Ma X; Wang T; Lu R; Jia X; Leng Z; Kong X; Zhang J; Li L
Int Immunopharmacol; 2023 Mar; 116():109729. PubMed ID: 37800555
[TBL] [Abstract] [Full Text] [Related]
10. Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
Sun Y; Zhou X; Lucas E; Chen L; Zhang H; Chen H; Zhou F
J Pathol Clin Res; 2024 Jan; 10(1):e345. PubMed ID: 37798754
[TBL] [Abstract] [Full Text] [Related]
11. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
[TBL] [Abstract] [Full Text] [Related]
12. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
[TBL] [Abstract] [Full Text] [Related]
13. A sensitive and rapid electrochemical biosensor for sEV-miRNA detection based on domino-type localized catalytic hairpin assembly.
Li W; Wang W; Luo S; Chen S; Ji T; Li N; Pan W; Zhang X; Wang X; Li K; Zhang Y; Yan X
J Nanobiotechnology; 2023 Sep; 21(1):328. PubMed ID: 37689652
[TBL] [Abstract] [Full Text] [Related]
14. The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy.
Tsang C; Robinson J; Wheatley-Price PF; Brule SY; Moore SM
Cancer; 2023 Dec; 129(23):3815-3819. PubMed ID: 37665180
[TBL] [Abstract] [Full Text] [Related]
15. Establishing the Learning Curve of Laparoscopic and Robotic Distal Gastrectomy: a Systematic Review and Meta-Regression Analysis.
Chan KS; Oo AM
J Gastrointest Surg; 2023 Dec; 27(12):2946-2982. PubMed ID: 37658172
[TBL] [Abstract] [Full Text] [Related]
16. ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells.
Xu H; Li P; Ma H; Tan Y; Wang X; Cai F; Xu J; Sun H; Zhuang H; Hua ZC
Cancer Med; 2023 Aug; 12(16):17193-17211. PubMed ID: 37492969
[TBL] [Abstract] [Full Text] [Related]
17. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/Nrf2 pathway.
Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
[TBL] [Abstract] [Full Text] [Related]
18. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells.
Kitajima H; Maruyama R; Niinuma T; Yamamoto E; Takasawa A; Takasawa K; Ishiguro K; Tsuyada A; Suzuki R; Sudo G; Kubo T; Mitsuhashi K; Idogawa M; Tange S; Toyota M; Yoshido A; Kumegawa K; Kai M; Yanagihara K; Tokino T; Osanai M; Nakase H; Suzuki H
Cell Death Dis; 2023 Jul; 14(7):424. PubMed ID: 37443145
[TBL] [Abstract] [Full Text] [Related]
19. Futibatinib, an Irreversible fgfr1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.
Javle M; King G; Spencer K; Borad MJ
Oncologist; 2023 Nov; 28(11):928-943. PubMed ID: 37390492
[TBL] [Abstract] [Full Text] [Related]
20. The Role of H2-Calponin Antigen in cancer Metastasis: Presence of Autoantibodies in Liver cancer Patients.
Bin X; Luo Y; Sun Z; Lin C; Huang P; Tu Z; Li L; Qu C; Long J; Zhou S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373013
[TBL] [Abstract] [Full Text] [Related]
[Next]
